Sky Air Ambulance in Guwahati: Air Medical Transportation with Utmost Care and Watchfulness

A few months back, a person gets stuck in remote areas of Guwahati, and his leg got fractured badly. The treatment is not possible in Guwahati due to the absence of experts at that time. One of his relatives reached our helpdesk and wants to get the relocation service to reach Kolkata immediately. As soon as we got to know the complete incidents, we sent the curative ambulance vans to the doorstep of the patient. Here he relocated to the air station with utmost ease. Finally, after the final preparations, we at Charter Air Ambulance Services in Guwahati shifted that patient from the airport to the designated place in Kolkata. After the successful transfer, we got to know that the patient was treated well. We took good care of him that’s why he didn’t get unstable during the transfer process. The transfer service bookings available for solemnly ill patients are open all around the clock. Anyone with an emergency can reach the helpdesk of Excellent Air Ambulance from Guwahati and get the well-scheduled patient transfer service in crises. We have expert telecom staff that helps in processing the emergency evacuation booking timely. We always process the evacuation with the presence of an expert medical team that takes care of patients conveniently.

More@ https://www.skyairambulance.in/air-ambulance-service-kolkata/

Web@ https://www.skyairambulance.in/air-ambulance-service-guwahati/

This announcement follows a series of brand recognitions for Bona Fide Masks from globally acclaimed mask manufacturer, Powecom. In August, Powecom recognized Bona Fide Masks as its largest and #1 Distributor in the U.S. and Canada. Bona Fide Masks then developed and went to market as the Exclusive Distributor for the Powecom KN95-SM.

Bona Fide Masks is part of a family-owned and -operated group of companies known for brand commitments that include transparency, honesty, authenticity, and supply chain integrity. These qualities have established Bona Fide Masks as the trusted source for masks in a confusing marketplace. Since its inception, Bona Fide Masks has established direct relationships with internationally recognized mask providers like Powecom and Harley Commodity. This exclusive relationship between Bona Fide Masks and Powecom reinforces their mutual commitment to delivering high-level, authentic masks to their North American customers.

"We are thrilled to expand our relationship with Powecom as its Exclusive Distributor in the U.S. and Canada. Bringing authentic, high-quality masks to everyone who needs them through supply chain strength, integrity and transparency has been my number one focus. I am very proud of our accomplishments, and we will continue to work hard daily to bring authentic masks that meet standards at an affordable price to all. As the only mask provider with exclusive KN95 distribution rights in North America, Bona Fide Masks has strengthened its position as the most trusted mask provider. By acquiring the Powecom® trademark, we are committed to protecting brand reputation and increasing buyer confidence. With so many counterfeit products on the market, our goal is to help keep customers safe by continuing to deliver authentic masks. We remain steadfast in our pursuit of excellence and our commitment to do the right thing for our customers, particularly during these challenging times. Lastly, I want to thank Powecom and their highly accomplished team for working with us." - Bill Taubner, President of Ball Chain and Bona Fide Masks. 

"Bona Fide Masks was the obvious partner for us. By naming Bona Fide Masks as the Exclusive Distributor of Powecom KN95 masks in the U.S. and Canada, we hope consumers will buy directly from them to ensure they are purchasing authentic and legitimate Powecom masks, made to the new GB2626-2019 standard. Protecting people is what our company is about, and naming Bona Fide Masks as the Exclusive Distributor will help us achieve our objectives." - Jing Yip, Powecom's Marketing and Export Officer.

To learn more about Bona Fide Masks, visit www.bonafidemasks.com.

More about Ball Chain Manufacturing Co., Inc.:

Family owned and operated since 1938, Ball Chain is the only major U.S. manufacturer of metal ball chain and attachments. The company's ball chain is featured in window roller shades, light fixtures, plumbing devices, keychains and jewelry items. Headquartered in Mount Vernon, New York. With global distribution, Ball Chain designs and fabricates innovative products while providing exemplary customer service. After entering the interior design market with ShimmerScreen® decorative metal curtains, the company further diversified its offerings with the launch of LogoTags, a promotional products division. Ball Chain is proud of its commitment to the American workforce and the environment. The company has earned industry recognition for its responsible business practices, including "green business" certification from the Green Business Bureau (GBB) and certification from the International Organization for Standardization (ISO).

Media Contact: 914.664.7500

Bill Taubner, President, bill@ballchain.com

Cristina Chianese, Director of Marketing & Public Relations

Ball Chain Mfg. Co., Inc. / Bona Fide Masks Corp.

info@bonafidemasks.com

As a multi-vendor platform, FibroNest is compatible with all kinds of digital image formats, including conventional digital pathology-stained slides (Picro Sirius Red, Trichrome or Antibody stains for fibrosis) acquired by both FDA-approved, digital pathology scanners and other digital microscopes.

At the 2021 AASLD | The Liver Meeting Digital Experience™ (TLMdX), PharmaNest and its world-class academic and industry collaborators present results that demonstrate the translational capabilities of FibroNest across the drug discovery and development continuum including:

The quantification of the progression of fibrosis in Human in-vitro 3D NASH tissue models and their response to Alk5 inhibitors and anti-TGB beta treatments - showing the utility of the combined technologies to accelerate the discovery of novel anti-fibrotic compounds, in a collaboration with InSphero (Schlieren, Switzerland).

The comparison of Whole Slide Digital Imaging and Two Photon (Second Harmonic Generation) digital imaging using FibroNest™ to evaluate the anti-fibrotic and anti-steatotic effects of FXR agonists in Leptin-deficient mice food with high-fat diets (NASH model), in a collaboration with Intercept, Inc. (New York, USA).

The development and validation of a highly sensitive, continuous digital pathology score, used to classify patients between NASH Fibrosis stages of F2 and F3, with a sensitivity and specificity performance of more than 90%, in a collaboration with Virginia Commonwealth University (Richmond, USA), Bristol Myers Squibb (Princeton, USA) and University of California (San Diego, USA).

The quantification of the histological phenotypes of fibrosis in LEAN and OBESE patients with NAFLD and F2 / F3 fibrosis, and the comparison of these phenotypes, in a collaboration with the Yokohama City University School of Medicine (Yokohama, Japan) and The Chinese University of Hong Kong (Hong Kong).

The development of a digital pathology score to automatically classify F1 NASH patients into sub-stages, such as F1a, F1b and F1c, in a collaboration with Lipocine, Inc (Salt Lake City, USA) and University of California (San Diego, USA).

In addition, several other communications at AASLD | TLMdX, 2021 will present the contribution of FibroNest's Digital Pathology and Quantitative AI platform in the quantification of novel drugs investigated in Phase2b studies, such as the LPCA 1144 Therapy (a collaboration with Lipocine, Inc., Salt Lake City, USA).

These results will be presented at The Liver Meeting Digital Experience™ (TLMdX) 2021 at the following poster presentations.

Please contact PharmaNest to schedule one-on-one or group webinar presentations.

AASLD "Poster of Distinction":

#1704 - Is the histological phenotype of Fibrosis different between LEAN and OBESE NASH patients? Michihiro Iwaki (1), Li Chen (2), Mathieu Petitjean (2), Atsushi Nakajima (1), Vincent Wai-Sun Wong (3) - (1) Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Japan (2) PharmaNest Inc, Princeton, New Jersey, USA (3) Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. 

#1601 - Evaluation of the multivendor performance of a novel histology-based fibrosis phenotypic composite score and its correlation with NASH-CRN Fibrosis scores in patients with NASH Li Chen (1), Michael Lung (2), Cynthia Behling (3), Anthony Azzara (4), Diane Shevell (4), Arun J. Sanyal (5), Mathieu Petitjean (1) - (1) PharmaNest, Princeton, NJ, USA (2) Pacific Rim Pathology, San Diego, CA, USA (3) Department of Pediatrics University of California, San Diego, CA, USA (4) Bristol Myers Squibb, Princeton, NJ, USA (5) Virginia Commonwealth University, Richmond, VA, USA

#LP41 - LPCN 1144 Therapy demonstrates Histologic Benefits in the Phase2 LiFT Study in NonAlcoholic Steatohepatitis (NASH) Subjects. Arun J Sanyal (1), Benjamin J Bruno (2), Kilyoung Kim (2), Shadi Mehraban (2), Kongnara Papangkorn (2), Anthony DelConte (2),(3), Nachiappan Chidambaram (2) and Mahesh V Patel (2), (1) Div of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA, (2) Lipocine Inc., Salt Lake City, UT, USA, (3) Department of Pharmaceutical/Healthcare Marketing, Saint Joseph's University, Philadelphia, PA, USA

#1908 - Digital Pathology Image Analysis Accurately Quantifies Anti-fibrotic and Anti-steatotic effects of FXR Agonists Using Multiple Histological Methods. Li Chen (1), Mary Erickson (2), Luciano Adorini (2), Jonathan Roth (2), Mathieu Petitjean (1) - 1 PharmaNest, Princeton, USA, 2 Intercept Pharmaceuticals, San Diego, USA

#1587 - Continuous staging of NASH Patients at low (F1) Fibrosis Severity: Evaluation of the performance of a novel histology-based fibrosis phenotypic composite score and predictive AI tools. Li Chen (1), Dmitry Fedorov (2), Mathieu Petitjean (1), Benjamin J. Bruno (3), Kilyoung Kim (3), Cynthia Behling (4), Anthony DelConte (5), Nachiappan Chidambaram (3)  - (1) PharmaNest Inc, Princeton, New Jersey, USA (2) ViQi Inc, Santa Barbara, California, USA (3) Lipocine Inc. Salt Lake City, Utah, USA (4) Pacific Rim Pathology, San Diego, CA, USA (5) Saint Joseph's University, Philadelphia, PA, USA

# 1183 - SB CCA.Mdr2-/-, a new mouse model of Cholangiocarcinoma arising in the PSC-like settings of progressive biliary injury and fibrosis. Pinzhu Huang1, Guangyan Wei 1, Shuangshuang Zhao1, Disha Badlani1, Kahini Vaid1, Li Chen2, Mathieu Petitjean2, Xin Chen3, Gregory Gores4, Yury Popov1 - (1) Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, (2) PharmaNest, Inc, Princeton, NJ, (3) University of California, San Francisco, CA and (4) Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN

#1362 - Evaluation of anti-fibrotic effects of compounds in human 3D NASH model using phenotypic quantification of fibrosis digital pathology images. Li Chen (1),Simon Strӧbel (2), Mathieu M. Petitjean (1), Eva Thoma (2), Radina Kostadinova (2) (1) PharmaNest, Princeton, NJ, USA (2) InSphero AG, Schlieren, Switzerland

PharmaNest | Press contacts

Dr. Mathieu M.  Petitjean

CEO

Mathieu.petitjean@pharmanest.com

Source: https://www.newswire.com/news/pharmanest-announces-new-pre-clinical-and-clinical-nash-data-to-be-21552258

"It is with great excitement that we announce the arrival of our InsulCheck DOSE by Innovation Zed. As the third generation product of the InsulCheck family, this technology has been a dream of our company from its very inception and this product is the culmination of over a decade of work to support multiple daily injection (MDI) pen users. We understood the difficult challenges presented by various injection pens and in particular the difficulties in working on a technology to reliably and accurately support low-cost disposable pens. This is the reason we at Innovation Zed took an incremental approach to developing the InsulCheck DOSE product." - said Dr Dean Minnock, CEO at Innovation Zed. "We have taken a unique approach in developing this technology by working closely with users, caregivers, software developers, medical device specialists and previous generations of InsulCheck products to design and develop a product that bolsters and supports the needs of all stakeholders'' - he continued.

What is InsulCheck DOSE?

InsulCheck DOSE Features

Value Proposition

Conclusion

American Medical Care, the leading medical facilitator in the US, is increasing its medical tourism facilities and localities worldwide to offer the best elective and non-elective treatments at competitive costs with no compromise on the high-quality service. 

American Medical Care offers extraordinary healthcare solutions with a mission to provide high-quality medical and surgical services at affordable costs. With an office in Washington, DC, we have the best team of medical facilitators with the right qualifications and enough experience to make the medical tour for patients an enjoyable experience. It is because of our innovative and effective ways of improving the healthcare of our clients. 

Our commitment to quality healthcare services striving to increase our expertise makes us one of the leading medical facilitators in the US. And our reliable service to clients with utmost care and concern at affordable costs makes us trusted by thousands worldwide. In addition, we provide our clients' dynamic experience rather than having the suffering of treatments with our following medical and health facilities. 

Identify the best doctors & clinics

The significant concern for people wishing to take a medical tour is the doctor's and the clinic's quality to undergo cosmetic, elective, or non-elective treatments. Since we have a network of the best doctors, surgeons, and clinics worldwide, our clients can benefit from it. They can cross-check from their end to know the credentials of our references to choose the best among several of them.

Help communicate better

For many clients who want to speak to the doctor or the clinic before embarking on the medical tour, we arrange a virtual meeting between them, breaking language barriers to gain confidence for their surgery or other treatments.

Travel & accommodation facilities

Being one of the leading medical facilitators servicing thousands of clients every year, we make all the travel and accommodation facilities to our clients in the best way possible. Also, we arrange the after treatment facilities for our clients to not worry about it. 

Offer affordable costs

We understand the need for the clients to take on a medical tour to save costs. Hence, with our experience and network, negotiate with the healthcare centers to offer reduced costs for our clients' treatments. And a perfect schedule with a budget of all the incurring costs will be ready for our clients to know if it is affordable before catching the flight for the treatment. 

We are increasing our facilities to many states in the US and our locations worldwide, from Mexico to Nigeria.

Sehaa online serves a wide scope of things for the most part taking into account the senior system. The things are exceptionally curated recalling the comfort and opportunity of the more established individuals. From the lifestyle to general wellbeing, these things target making the ordinary presence of the more established people basic and trouble-free. 

With the help of a wide extent of things, we target giving the seniors all the assistance and care that they require while beginning their ensuing innings, to help them with achieving a free lifestyle. 

It's a standout amongst other online retail chains and gives a one-stop objective to offer a lifestyle and prosperity responses for the senior system. SehaaOnline is an online answer for social insurance items including best overall clinical brand names in different classes. Built-up in 2015, Sehaaonline focuses on managing your Health Care needs. With everywhere throughout the UAE reach, we offer in excess of 2,500 things in 20 one of a kind classifications. 

At sehaaonline.com, we grasp that buying TENS machine online Dubai is a basic choice. We give it a second thought and are consistently present for any help. Our business is guided by four measures: master counsel, conveyance on schedule, quality, and accommodation. We offer master exhortation through a wide one-on-one customer organization, from item assurance to after-deal administrations. Through our over the national circulation organize and submitted staff, sehaaonline.com centers around on-time conveyance. 

WIth major overall brands working with us, we give you the best accessible quality on the planet. Through 24-hour site availability and our cost-free number, we offer our customers accommodation. 

Basic errands can normally seem, by all accounts, to be hard for seniors due to deficiencies and conditions like Arthritis and Osteoporosis. Certain rigging and embellishments and APM Air pressure sleeping cushion Dubai can assist seniors with carrying on with a sound and dynamic lifestyle. A wide extent of things associated with arrangements like Easy Living Accessories, Hot and Cold Therapy, Massagers and Pain Relief, and Medical Equipment are expected to give the fundamental thought and support to the seniors. 

With age, seniors every now and again lose quality and balance and are defenseless to issues relating to compactness. In order to give the seniors security, comfort and empower free living, we bring to you a wide extent of versatility helps that joins Walkers and rollators, Walking Stick and Crutches, Wheelchairs, best enemy of slip covering for washroom floor tiles in Dubai and some more.

Contact Us
Sehaa Online Dubai
27, Marina Plaza
Dubai
112229
United Arab Emirates
Tel: +971585979509
Email: sehaaonlinedubai@gmail.com
Website: https://sehaaonline.com

           In the meantime, chloroquine/hydroxychloroquine continued as the interim treatment for COVID-19 infections; despite the absence of corroborating clinical studies of its successful treatment for COVID-19 infections.  Instead, the following reports [1-8] have refuted the claims of chloroquine/hydroxychloroquine effective treatment of infected patients.            

          The failure of chloroquine/hydroxychloroquine treatment has led to a race to be first with a cure for COVID-19.   Most claims of successful treatments for Covid-19 infections have been anecdotal and uncorroborated. They have not been subjected to the evaluation and scrutiny required for the publication in a reputable journal.  Even those that are published, most often do not adhere to the conditions required for the “scientific method” approach and its conclusions. The consequence is represented by the admonition of Claude Bernard (the “father" of the scientific method ): “If men (or women) discuss and experiment to prove a preconceived idea in spite of everything, they no longer have freedom of mind, and they no longer search for truth.” That is applicable to most COVID-19 treatment reports, which are not consistent with the scientific method approach.  

          Dr. Anthony Fauci (the NIH/NIAID Director) subsequently recognized the failure of   chloroquine/hydroxychloroquine treatment.  He is now promoting remdesivir as the interim treatment, while awaiting the development of new medications.  Remdesivir decreases the recovery time for COVID-19 patients from 15 to 11 days (27%) [9] (https://www.mdedge.com/hematology-oncology/article/221518/coronavirus-updates/remdesivir-now-standard-care-covid-19-fauci).  Remdesivir interferes with the replication of the virus. However, it does not terminate the infection or the coronavirus. 

However, thousands of new cases and deaths will occur before new drugs are available. That would be avoided by the treatment with 3% Clioquinol Cream, which already exists.    Animal model studies [10] demonstrated that clioquinol treatment results in 85% inhibition of human prostate cancer tumor growth. That information provided the basis for employing 3% Clioquinol Cream in the treatment of a patient with terminal advanced prostate cancer. It resulted in the termination of the malignancy; the first case report [11] of a successful treatment for that malignancy. For two years since the treatment, the patient has no adverse side effects, and he has resumed his normal activities. 

The basis for that successful treatment is that, compared to normal cells, malignant cells exhibit decreased zinc and the downregulation of their zinc-uptake transporter. That malignant transformation prevents the uptake and accumulation of the high zinc level that exists in the normal cells; but is cytotoxic in the malignant cells.  Therefore, an agent that facilitates the transport of zinc will terminate the malignancy.  

Clioquinol is a zinc ionophore that has the ideal properties to deliver achieve zinc cytotoxicity.      ZnClioquinol has a zinc-binding affinity of logKf=7-8; which is ideal for the competitive binding of most of the plasma zinc that exists in the exchangeable ZnLigands. When 3% Clioquinol Cream Cream is massaged into the skin, the clioquinol is absorbed into the blood plasma; and it binds to the exchangeable zinc.  ZnClioquinol is delivered to the malignancy site and binds to the cell membrane. The zinc is transferred from ZnClioquinol into the cytosol. There, the zinc binds to the ligands that result in cytotoxic effects, and terminate the malignancy. 

Support is also provided by the Krenn et al 1999 report [12], which concluded:  “We provide evidence that both pyrithione and hinokitiol (zinc ionophores) inhibit replication of picornaviruses by impairing viral polyprotein processing. The basis of the antiviral activity is dependent upon the availability of zinc ions. We show that the import of extracellular zinc ions is a key feature of the common antiviral property of these compounds.”  The advantageous zinc ionophore properties of clioquinol enhances the expectation that 3% Clioquinol Cream will be an efficacious medication for the prevention and treatment of Covid-19 infections, and will induce coronavirus cytotoxicity and death. 

In contrast, chloroquine zinc ionophore (ZnChloroquine) has a logKf=5-6.  Consequently, it competitively binds with much less zinc that is delivered to the malignant site.  That is a reason for the ambivalent, if any, effects of chloroquine/hydroxychlororquine. The poor zinc ionophore properties of chloroquine/hydroxychlororquine dictate that it should not be promoted for the treatment of COVID-19.  Instead, 3% Clioquinol Cream is more effective and should be recommended.  

              An issue of clioquinol toxicity is often raised.  It is based on an occurrence of subacute myelo-optic neuropathy (SMON) in a Japanese population around 1980 that was experiencing an epidemic of intestinal amoebiasis.   Publications [13,14] that reviewed the incident established that SMON was not linked to clioquinol in other populations; or even in Japan, aside from this one incident.  They established that the excessive use of 250 mg clioquinol tablets was the cause of the SMON; and concluded: “Over-readiness to accept postulated toxic effects of medicines and chemicals as proven is likely to do at least as much harm as good to the individual and the community health”. 

Summary:  Collectively, the information provides extensive evidence that 3% Clioquinol Cream will be an effective and safe chemotherapy for the prevention and treatment of COVID-19 infections. The administrators at the FDA, CDC, NIH NIAID, and other members of the medical community, and the political community should consider that:

•         1. Hydroxychloroquine has been revealed to be ineffective as an efficacious chemotherapy for the treatment of COVID-19 infections.

·                2. Administrators at FDA, CDC, NIAID, and others subsequently recognized the above relationships; and no longer promote chloroquine/hydroxychloroquine.

·                3. Remdesivir is now promoted for the treatment of COVID-19 in interferes with the replication of the virus. It does not terminate the infection or the coronavirus.  It is the interim treatment until new medications are developed.

·                4. It is not necessary to wait 1-2 years for the development of effective new medications; during which time, thousands of COVID-19 cases and deaths will occur in the U.S. and worldwide.

·            5. 3% Clioquinol Cream is an efficacious treatment for malignancy.

•         6.  3% Clioquinol Cream should also be an effective chemotherapy for COVID-1 infections.       

•         7.  Without further delay, physicians can prescribe 3% Clioquinol Cream for the “off label” and “right to try” treatment for COVID-19 infection. 

·                8. If successful, the FDA should proceed with clinical trials for approving 3% Clioquinol Cream specifically for the treatment of COVID-19 infections.

References

1. Colson P, Rolain JM, Raoult D.  Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Internat J Antimicrob Agents. 55: 1-2, 2020.

2. Gatlin A.  Covid Report: A Trump-Touted Malaria Drug Flops In Coronavirus Treatment. Invest Business Daily; Apr 24, 2020

3. Ferner RE, Aronson JK. The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. April 14, 2020.

4. Kasprak A. Has Dr. Zelenko Successfully Treated 669 Coronavirus Patients?  Snopes; Mar 30, 2020

5. Di Tranic L,  Donatelli I, Cauda R, Cassone A. New insights into the antiviral effects of chloroquine. The Lancet Infect Dis; 6: 67-69, 2006

6. Wang M, Cao R, Zhang L, Yang X,  Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 30:269–271, 2020

7.  Lowe D.  Hydroxychloroquine Update For April 6. In the Pipeline. Science Translat Med;  6 April, 2020.

https://blogs.sciencemag.org/pipeline/archives/2020/04/06/hydroxychloroquine-update-for-april

8.   Savarino A, Di TranicIs L,   Donatelli B, Cauda R, Cassone A.  New insights into the antiviral effects of chloroquine. The Lancet Infect Dis;  667-669:   , February 2006, Pages

9.  Fox M, Gumbrecht J, Yan H, Klein B. FDA will reportedly authorize use of remdesivir for Covid-19 after trial shows 'positive effect' on recovery time. CNN Health; April 30, 2020

https://www.cnn.com/2020/04/29/health/gilead-sciences-remdesivir-covid-19-treatment/index.html

10. Costello LC, Franklin RB, Zou J, Naslund MJ. Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach. Chemotherapy (Los Angel); 4:152,2015.

11. Costello LC, Franklin RB, Yu GW. A Novel Patient Case Report to Show the Successful Termination of Untreatable Androgen-independent Prostate Cancer: Treatment with Cabergoline (Dopamine agonist). Mathews J Case Rep; 4:42,2019.

12. Krenn BM, Gaudernak E, Holzer B, Lanke K, Van Kuppeveld FJM, Seipelt J. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J Virol; 83:58–64, 2009.

13. Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther. 2012;18(1):41‐46, 2012.

14. Mao X, Schimmer AD. The Toxicology of Clioquinol. Toxicol. Letters; 182:1-6, 2008.

In a world where life has become a competition and no time is left for ourselves and our loved ones, Children are the ones who have been affected the most. Now the question arises how? The answer to this is not easy. There have been studies and research conducted worldwide to understand how children get affected by psychology if they are not given proper attention by the parents or guardians. If you stay in Gurgaon or NCR, Child psychologists in Gurgaon can be consulted easily which we will share later in the article. 

According to various Child psychologists globally, children if left unattended lead to getting susceptible to moods like anger and stubbornness. And this is mainly because they are seeking attention from their parents. There are other reasons like being harassed by someone and a child not sharing it with his parents leads to the accumulation of thoughts inside and leads to strange behavior. There have been numerous cases of peers teasing them leading to depression-like symptoms in the loss too. So, it is advisable that if any odd or strange behavior is seen in kids, a specialist in treating such children should be consulted which is a child psychologist.

Plunes is one of a kind utility network for all medical services where benefits like booking an appointment for procedures, diagnostic and consultation can be done on a single click. It acts like your personal assistant in this case. From locating the nearest clinic to making sure you get the best one or does that all for you. The first consultation is free and even for the telephonic consultations, you do not get charged too. After these, or also carries a unique feature where the reports after your diagnosis can be downloaded from your account on the app where it gets stored automatically It’s like no mess any more for any needs related to medical service. 

Special care. The goal of the treatment center is to help people detox from substances and devise a treatment plan that will sustain recovery throughout the rest of their lives. We are equipped to treat addictions for alcohol, benzodiazepines, opioids, and addictions to other substances.

Understanding. The coronavirus has brought new anxieties and fears to our lives. It has caused many to worry about themselves and their loved ones.

As a result of this pandemic, many people are using drugs and alcohol at unprecedented levels. Many are using substances as a way to self-medicate and deal with their depression and anxiety. For those individuals who already suffer from depression and anxiety the current issues related to COVID-19 exacerbate their symptoms.

"We are ready to counter the psychological fall-out of COVID-19 with professional and effective defense," says Brent Bowers, Director West Valley Detox. "We have several years of treatment-specific experience in the detox and the rehabilitation field providing the best results for our patients."

The very fact of opening a new professional detox center is of great importance and is sorely needed. According to statistics almost 21 million Americans have at least one addiction, yet only 10% of them receive treatment.

The treatment center is scheduled to open today despite the pandemic. We are eager to offer services to those who have self-quarantined and have suffered silently with depression, anxiety and substance use disorders.

Detoxification, or detox, is a process that allows you to remove drugs from the body. The detox procedure for drug addiction is not a substitute for treatment.

Typically, complex treatment includes:

• Complete body cleansing not only from the drug but also from the products of its decay. It is especially important to remove the poison from adipose tissue, where it can persist for years.
• Helping the internal organs to restore their normal performance.
• Restoring the body defenses.
• Bringing metabolic processes to normal.
• Work aimed at restoring the nervous system and mental state of the addict.

All these are serious and important steps to recovery. These steps are best carried out under the close supervision of qualified and experienced treatment specialists like the staff at West Valley Detox.

"We are with you and we will help you!" - says Brent Bowers, Director, West Valley Detox.

Source - https://www.newswire.com/news/west-valley-detox-safety-measures-during-covid-19-21153760

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 175,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.

ABOUT SUPPLIER

Metrex Research, LLC (Metrex) works to provide value-added infection prevention products and services in global healthcare environments. We offer a complete line of high-quality enzymatic detergents, high-level disinfectants/sterilants, surface disinfectants for use in hospitals, liquid medical waste disposal products, hand hygiene products, eye shields and many other infection prevention products. Our products are specifically designed for healthcare markets such as acute care, primary care, ambulatory surgery centers (ASC), EMS/Fire/Police, extended care, and the public sector.

Source - https://www.newswire.com/news/metrex-research-llc-awarded-high-level-disinfectant-ascend-agreement-21156692

Today, we are excited to announce the rebirth of AKSP, depicted by our new logo raising ASKP to the power of 3. The ASKP name has changed from the American Society of Ketamine Physicians to the American Society of Ketamine Physicians, Psychotherapists & Practitioners. The next generation of this society reflects full inclusion of multiple disciplines who are called to lead and contribute: physicians, psychologists, other psychotherapists, advanced practice providers, pharmacists, patients, and others. The leadership role of mental health professionals, psychiatrists, and psychotherapists, in the management of depression, anxiety, suicidality, and substance use disorders is also recognized. A premise of this organization is that ketamine offers an opportunity that reaches beyond any one specialty and calls for close collaboration between professionals who understand and prescribe ketamine and professionals who understand mental health and pain.

At our recent membership meeting, our board presented this new vision and updated bylaws. The new bylaws were recently ratified by the membership and adopted by the society. This new vision allows us to be more inclusive of membership and to make changes to advance the organization. We will be adding advisory panels to the board as well as expanding the board. The board will continue to have a majority of physicians, derived from several specialties including psychiatry, anesthesia, and emergency medicine. In addition, the board will have at least one psychotherapist, at least one advanced practice provider and one non-voting patient advocate. We also adopted a new mission and vision statement which can be viewed on our website.

Lastly, our board consists of the same members, but we have selected new officers to carry forth our new vision. Dr. Sandhya Prashad, a psychiatrist, is our new president, Dr. Megan Oxley, an emergency medicine physician, is our vice president. Our new secretary is Dr. Cindy Van Praag, an anesthesiologist and Dr. Robert Grant, a physician specialized in internal medicine and pulmonary medicine, is our new treasurer. These new officers bring a variety of expertise to the organization to pave the way in carrying out our new mission and vision.

For anyone interested in the therapeutic use of ketamine, we welcome you to join ASKP³. Benefits of ASKP³ membership include voting for leadership, the opportunity to join advisory panels, as well as run for a seat on the board of directors and officer positions, a discount on conference registration, access to member-only educational webinars, and a members-only forum for discussion and queries.

Source - https://www.newswire.com/news/the-american-society-of-ketamine-physicians-askp-announces-name-change-21155846